ASSOCIATION OF FAILURES OF SEVEN-DAY COURSES OF ARTESUNATE IN A NON-IMMUNE POPULATION IN BANGUI, CENTRAL AFRICAN REPUBLIC WITH DECREASED SENSITIVITY OF PLASMODIUM FALCIPARUM

DIDIER MENARD Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by DIDIER MENARD in
Current site
Google Scholar
PubMed
Close
,
MARCELLE DIANE MATSIKA-CLAQUIN Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by MARCELLE DIANE MATSIKA-CLAQUIN in
Current site
Google Scholar
PubMed
Close
,
DJIBRINE DJALLE Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by DJIBRINE DJALLE in
Current site
Google Scholar
PubMed
Close
,
FERDINAND YAPOU Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by FERDINAND YAPOU in
Current site
Google Scholar
PubMed
Close
,
ALEXANDRE MANIRAKIZA Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by ALEXANDRE MANIRAKIZA in
Current site
Google Scholar
PubMed
Close
,
VIRGINIE DOLMAZON Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by VIRGINIE DOLMAZON in
Current site
Google Scholar
PubMed
Close
,
JACQUES SARDA Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by JACQUES SARDA in
Current site
Google Scholar
PubMed
Close
, and
ANTOINE TALARMIN Institut Pasteur de Bangui, Bangui, Central African Republic; Centre Médico-Social de l’Ambassade de France à Bangui, Bangui, Central African Republic

Search for other papers by ANTOINE TALARMIN in
Current site
Google Scholar
PubMed
Close
Restricted access

We assessed the efficacy and safety of a seven-day course of artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in 55 non-immune patients living in Bangui, Central African Republic. The parasitologic cure rates were 100%, 95%, and 85% on days 14, 28, and 42, respectively. There were no significant differences in parasitemia density, 50% inhibitory concentration of dihydroartemisinin, and frequency of mutant P. falciparum multidrug resistance 1 codon 86 between patients who were cured and those who displayed recrudescence. However, the 90% inhibitory concentration for dihydroartemisinin and the number of genotypes isolated were both higher in the recrudescent patients (five- and two-fold, respectively). We found an association between recrudescence and decreased sensitivity. This suggests that the use of artemisinin compounds alone will select resistant strains. We conclude that artesunate should not be used in monotherapy even in seven-day courses, but only in combination with other anti-malarials to prevent the emergence of resistant P. falciparum.

Author Notes

  • 1

    Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull World Health Organ 80 :538–545.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Kazadi WM, Vong S, Makina BN, Mantshumba JC, Kabuya W, Kebela BI, Ngimbi NP, 2003. Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health 8 :868–875.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Ndong JM, Atteke C, Aubouy A, Bakary M, Lebibi J, Deloron P, 2003. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.Trop Med Int Health 8 :25–29.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Nsimba B, Malonga DA, Mouata AM, Louya F, Kiori J, Malanda M, Yocka D, Oko-Ossho J, Ebata-Mongo S, Le Bras J, 2004. Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am J Trop Med Hyg 70 :133–138.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Pierce PF, Milhous WK, Campbell CC, 1987. Clinical and laboratory characterization of a chloroquine-resistant Plasmodium falciparum strain acquired in the Central African Republic. Am J Trop Med Hyg 36 :1–2.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Belec L, Delmont J, Vesters I, Testa J, Christian KS, Georges AJ, 1988. Emergence of multiresistant Plasmodium falciparum malaria in Central Aforcan Republic. Presse Med 17 :2090–2091.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Menard D, Madji N, Manirazika A, Djalle D, Koula MR, Talarmin A, 2005. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimeth-amine combination, and amodiaquine-sulfadoxine-pyrimeth-amine combination in Central African children with noncom-plicated malaria. Am J Trop Med Hyg 72 :581–585.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    de Vries PJ, Dien TK, 1996. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52 :818–836.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347 :1654–1658.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Borrmann S, Adegnika AA, Missinou MA, Binder RK, Issifou S, Schindler A, Matsiegui PB, Kun JF, Krishna S, Lell B, Kremsner PG, 2003. Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon. Antimicrob Agents Chemother 47 :901–904.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T, 1991. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J Trop Med Public Health 22 :539–543.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Li GQ, Guo XB, Fu LC, Jian HX, Wang XH, 1994. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg 88 (Suppl 1):S5–S6.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Alin MH, Kihamia CM, Bjorkman A, Bwijo BA, Premji Z, Mtey GJ, Ashton M, 1995. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Am J Trop Med Hyg 53 :639–645.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Ezedinachi E, 1996. In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria. Cent Afr J Med 42 :109–111.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Hassan Alin M, Ashton M, Kihamia CM, Mtey GJ, Bjorkman A, 1996. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg 90 :61–65.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    WHO, 2000. The Use of Antimalarial Drugs: Report of an Informal Consultation. Geneva: World Health Organization. November 13–17, 2000. WHO/CDS/RBM/2001.33. Available from http://rbm.who.int/cmc_upload/0/000/014/923/use_of_antimalarials.pdf.

    • PubMed
    • Export Citation
  • 17

    Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group, 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 :9–17.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Grace JM, Aguilar AJ, Trotman KM, Peggins JO, Brewer TG, 1998. Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450. Drug Metab Dispos 26 :313–317.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Lee IS, Hufford CD, 1990. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther 48 :345–355.

  • 20

    Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16 :710–718.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, Trape JF, Mercereau-Puijalon O, 1998. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg 59 :726–735.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Kimura E, Mattei D, di Santi SM, Scherf A, 1990. Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients. Gene 91 :57–62.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Borre MB, Dziegiel M, Hogh B, Petersen E, Rieneck K, Riley E, Meis JF, Aikawa M, Nakamura K, Harada M, 1991. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol 49 :119–131.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Duraisingh MT, Roper C, Walliker D, Warhurst DC, 2000. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum.Mol Microbiol 36 :955–961.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Molineaux L, Diebner HH, Eichner M, Collins WE, Jeffery GM, Dietz K, 2001. Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology 122 :379–391.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Nguyen DS, Dao BH, Nguyen PD, Nguyen VH, Le NB, Mai VS, Meshnick SR, 1993. Treatment of malaria in Vietnam with oral artemisinin. Am J Trop Med Hyg 48 :398–402.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Giao PT, Binh TQ, Kager PA, Long HP, van Thang N, van Nam N, de Vries PJ, 2001. Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am J Trop Med Hyg 65 :690–695.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G, 2003. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 68 :133–139.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    WHO, 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization. WHO/HTM/RBM/2003.50. Available from http://mosquito.who.int/cmc_upload/0/000/017/017/ProtocolWHO.pdf

    • PubMed
    • Export Citation
  • 30

    Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ, 2004. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother 48 :4271–4280.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Ringwald P, Bickii J, Basco LK, 1999. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 61 :187–192.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Thanh NV, Cowman AF, Hipgrave D, Kim TB, Phuc BQ, Cong LD, Biggs BA, 2001. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam. Trans R Soc Trop Med Hyg 95 :513–517.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Noedl H, Faiz MA, Yunus EB, Rahman MR, Hossain MA, Samad R, Miller RS, Pang LW, Wongsrichanalai C, 2003. Drug-resistant malaria in Bangladesh: an in vitro assessment. Am J Trop Med Hyg 68 :140–142.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S, 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Anti-microb Agents Chemother 43 :2943–2949.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Ittarat W, Pickard AL, Rattanasinganchan P, Wilairatana P, Looareesuwan S, Emery K, Low J, Udomsangpetch R, Meshnick SR, 2003. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am J Trop Med Hyg 68 :147–152.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Sokhna CS, Rogier C, Dieye A, Trape JF, 2000. Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. Am J Trop Med Hyg 62 :266–270.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    ter Kuile FO, Luxemburger C, Nosten F, Thwai KL, Chong-suphajaisiddhi T, White NJ, 1995. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 89 :660–664.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 540 501 196
Full Text Views 207 10 0
PDF Downloads 47 10 2
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save